Role of BCL2L10 Methylation and TET2 Mutations in Higher Risk Myelodysplastic Syndromes Treated With 5-Azacytidine
Leukemia - United Kingdom
doi 10.1038/leu.2011.170
Full Text
Open PDFAbstract
Available in full text
Date
July 15, 2011
Authors
Publisher
Springer Science and Business Media LLC